Table 5 Personal impact of headache assessed by HALT index (days lost in preceding 3 months), by diagnosis and gender
From: The impact of headache in Europe: principal results of the Eurolight project
Diagnosis and gender | Days lost (% [95% CI]) | |||
|---|---|---|---|---|
0-5 days | 6-10 days | 11-20 days | >20 days | |
Migraine | ||||
Males | 73.0 [±3.0] | 9.3 [±2.0] | 7.8 [±1.8] | 9.9 [±2.0] |
Females | 57.7 [±2.3] | 14.4 [±1.6] | 12.2 [±1.5] | 15.8 [±1.7] |
Tension-type headache | ||||
Males | 92.0 [±1.5] | 3.3 [±1.0] | 2.2 [±0.8] | 2.5 [±0.8] |
Females | 87.5 [±1.7] | 5.4 [±1.1] | 3.4 [±0.9] | 3.7 [±1.0] |
Probable medication-overuse headache | ||||
Males | 34.0 [±13.5] | 10.6 [±8.8] | 10.6 [±8.8] | 44.7 [±14.2] |
Females | 31.4 [±8.3] | 6.6 [±4.4] | 8.3 [±4.9] | 53.7 [±8.9] |